ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Next Generation of Clinical Trials
In this edition of PharmaTimes, ICON's Tom O’Leary comments on the next generation of trials in particular participant engagement, expansive data & digital tech
Navigating the Labyrinth of Regulation and Taking Drug Safety Reporting to the Next Level with Automation
An article on the challenges of global clinical trials in an ever-changing regulatory environment, and more.
Wearables in Virtual Trials
Connected health including wearable devices and mobile health (mHealth) technology, is providing an opportunity for patient-centric data.
Immunotherapy Combination Trials Q&A
A Q&A article discussing how best to achieve success in an increasingly crowded, competitive immuno-oncology field.
ICON Introduces New Drug Safety Reporting Solution
An Outsourcing Pharma article featuring commentary from Quintin Van Wyk on ICON’s new drug safety reporting platform.
Adopting a Strategy to Identify Highest Commercial Value Products
A thought leadership article written by Vicki Anastasi and published by JMDR exploring the challenges of transitioning to the new EU MDR and IVDR.
A Primer for Manufacturers Adjusting to Value-Based Healthcare
An article on the challenges of a value-based healthcare market and the importance of demonstrating clinical efficacy and cost impact of new devices.
ICON Rolls Out Digital Platform Developed with Dimension Data
An article on ICON’s new digital platform developed with Dimension Data.
Improving Pharma R&D Efficiency
Among Applied Clinical Trials' top articles on Industry Trends 2019, this article is based on ICONs whitepaper on key challenges in modern drug development.
Parkinson’s Disease Clinical Trials
An article exploring Parkinson’s disease clinical trials, featuring commentary from Peter Schueler and Haichen Yang.